1. Behbehani R, Sergott RC, Savino PJ. The antiphospholipid antibody syndrome: diagnostic aspects. Curr Opin Ophthalmol. 2004; 15:483–485.
2. Cobo-Soriano R, Sánchez-Ramón S, Aparicio MJ, et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol. 1999; 128:725–732.
3. Franchini M, Veneri D. The antiphospholipid syndrome. Hematology. 2005; 10:265–269.
4. Miserocchi E, Baltatzis S, Foster CS. Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol. 2001; 131:451–456.
5. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002; 346:752–763.
6. Montehermoso A, Cervera R, Font J, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum. 1999; 28:326–332.
7. Kleiner RC, Najarian LV, Schatten S, et al. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology. 1989; 96:896–904.
8. Nag TC, Wadhwa S. Histopathological changes in the eyes in systemic lupus erythematosus: an electron microscope and immunohistochemical study. Histol Histopathol. 2005; 20:373–382.
9. Shein J, Shukla D, Reddy S, et al. Macular infarction as a presenting sign of systemic lupus erythematosus. Retin Cases Brief Rep. 2008; 2:55–60.
10. Cooper BA, Shah GK, Grand MG. Purtscher's-like retinopathy in a patient with systemic lupus erythematosus. Ophthalmic Surg Lasers Imaging. 2004; 35:438–439.
11. Yoon CK, Park JH, Yu HG. Retinopathy associated with systemic lupus erythematosus. J Korean Ophthalmol Soc. 2009; 50:1215–1220.
12. Kim IT, Na SC, Lee KJ. Vascular occlusions associated with antiphospholipid antibodies in systemic lupus erythematosus. J Korean Ophthalmol Soc. 2000; 41:427–432.
13. Gass JD. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease: V. Retinal telangiectasis. Arch Ophthalmol. 1968; 80:592–605.
14. Lahey JM, Tunç M, Kearney J, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology. 2002; 109:126–131.
15. Castañón C, Amigo MC, Bañales JL, et al. Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology. 1995; 102:256–262.
16. Al-Abdulla NA, Thompson JT, LaBorwit SE. Simultaneous bilateral central retinal vein occlusion associated with anticardiolipin antibodies in leukemia. Am J Ophthalmol. 2001; 132:266–268.
17. Kim SG, Kim YY, Song GG, et al. Primary antiphospholipid syndrome associated with non-ischemic central retinal vein occlusion. J Korean Ophthalmol Soc. 1995; 36:525–530.
18. Au A, O'Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol. 2004; 32:87–100.
19. Hong-Kee N, Mei-Fong C, Azhany Y, Zunaina E. Antiphospholipid syndrome in lupus retinopathy. Clin Ophthalmol. 2014; 8:2359–2363.
20. Hu CL, Peng KL. Bilateral macular infarction as an ocular manifestation of systemic lupus erythematous (SLE). Clin Ophthalmol. 2014; 8:1845–1848.